Evidence map›Paper›PMID 42001002›Full record

ArticleBMC neurology2026

Subclinical peripheral nerve demyelination without overt symptoms in a family with neuronal intranuclear inclusion disease harboring biallelic repeat expansions.

Hang Zhang, Taiqi Zhao, Honglin Zheng, Suying Duan, Chenyang Liu, Yaochong Zhang, Qiang Li, Han Liu, Haiyang Luo, Yuming Xu

Abstract readCase Reports
In one paragraph

Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hang Zhang *Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Jian-She East Road, Zhengzhou, Henan, 450052, China.
Taiqi Zhao *Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Jian-She East Road, Zhengzhou, Henan, 450052, China.
Honglin Zheng *Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Jian-She East Road, Zhengzhou, Henan, 450052, China.
Suying DuanDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Jian-She East Road, Zhengzhou, Henan, 450052, China.
Chenyang LiuDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Jian-She East Road, Zhengzhou, Henan, 450052, China.
Yaochong ZhangDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Jian-She East Road, Zhengzhou, Henan, 450052, China.
Qiang LiDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Jian-She East Road, Zhengzhou, Henan, 450052, China.
Han LiuDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Jian-She East Road, Zhengzhou, Henan, 450052, China. fccliuh2@zzu.edu.cn.
Haiyang LuoDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Jian-She East Road, Zhengzhou, Henan, 450052, China. fccluohy@zzu.edu.cn.
Yuming XuDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Jian-She East Road, Zhengzhou, Henan, 450052, China. xuyuming@zzu.edu.cn.

Funding

the National Natural Science Foundation of China U1904207the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2020-PT310-01
6 · The paper itself

Abstract

Neuronal intranuclear inclusion disease (NIID) is a rare, progressive neurodegenerative disorder caused by abnormal GGC repeat expansions in the NOTCH2NLC gene, leading to multisystem involvement. Electrophysiological abnormalities in NIID have gained increasing attention in recent years. However, subclinical peripheral neuropathy preceding the onset of typical NIID manifestations has not been reported. In this study, we systematically evaluated the clinical characteristics of a family carrying pathogenic NOTCH2NLC expansions. Electrophysiological assessments revealed demyelinating changes in some family members, with or without the classic clinical features of NIID. Notably, one individual with biallelic NOTCH2NLC GGC repeat expansions exhibited subclinical peripheral neuropathy in the absence of overt NIID symptoms. As NIID is typically inherited in an autosomal dominant manner, cases with biallelic GGC repeat expansions are exceedingly rare. To explore the genotype–phenotype relationship, we employed long-read whole-genome sequencing using Oxford Nanopore and Pacific Biosciences (PacBio) technologies. Our results suggest that biallelic repeat expansions do not necessarily exacerbate the severity or progression of NIID. Although larger studies are warranted to confirm these findings, this investigation broadens the clinical and genetic spectrum of NIID and provides new insights into its underlying pathogenesis.

Indexed as

Demyelinating DiseasesIntranuclear Inclusion BodiesNeurodegenerative DiseasesPeripheral Nervous System DiseasesTrinucleotide Repeat ExpansionFemaleHumansIntercellular Signaling Peptides and ProteinsMaleMiddle AgedNerve Tissue ProteinsPedigreeIntercellular Signaling Peptides and ProteinsNerve Tissue ProteinsNOTCH2NLC protein, humanbiallelic GGC repeat expansionsdemyelinating lesionsNIIDOxford NanoporePacBioperipheral neuropathy

Identifiers

PMID42001002
PMCPMC13220522

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.